Back to Trades
WALTERS GROUP
10% OwnerCIK 0001177523
Profile
- Filings
- 3
- Buy transactions
- 2
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
WALTERS GROUP, 10% Owner, has filed 3 SEC reports (2026), all concentrated in Zentalis Pharmaceuticals, Inc. (ZNTL), totaling $22.9M in disclosed volume. Weighing $22.9M bought versus $0 sold, the history is heavily weighted toward buying. The largest single open-market purchase on record is $15.2M in Zentalis Pharmaceuticals, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| Aug 19 | ZNTL Zentalis Pharmaceuticals, Inc. | WALTERS GROUP | 10% Owner | Buy | $15.2M |
| Jan 8 | ZNTL Zentalis Pharmaceuticals, Inc. | WALTERS GROUP | 10% Owner | Buy | $7.8M |
| Jan 8 | ZNTL Zentalis Pharmaceuticals, Inc. | WALTERS GROUP | 10% Owner | Other | $0 |
3 filings